Answers are grounded in this paper and cite their sources.
Epinephrine has been the first-line treatment for severe allergic reactions including anaphylaxis for several decades. Historically, the approved epinephrine injection products by the US Food and Drug Administration (FDA) have been considered clinically comparable, with nearly identical product labeling. However, a growing body of evidence now suggests that there are substantive pharmacokinetic and pharmacodynamic differences among these products.1–4
No takes yet. Share an insight, caveat, or question.
Tanimoto et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: